A newly published paper in The Lancet shows that an experimental vaccine against Marburg virus (MARV) was safe and induced an immune response in a small, first-in-human clinical trial. The vaccine, developed by researchers at the National Institute of Allergy and Infectious Diseases (NIAID),
Washington [US], February 5 (ANI): During COVID-19, as the opioid epidemic raged on with an even greater force, researchers have been working on new therapeutic interventions that may be helpful in preventing the bulk of deaths due to opioid overdose.
Washington [US], May 06 (ANI): United States-based pharmaceutical giant Pfizer has begun testing multiple versions of an experimental vaccine in healthy young people in America.